U.S. markets open in 7 hours 59 minutes
  • GuruFocus.com

    RA Capital Management L.P. Increases Stake in Janux Therapeutics Inc

    On September 12, 2024, RA Capital Management L.P., a prominent investment firm, executed a significant transaction by acquiring an additional 1,577,341 shares of Janux Therapeutics Inc (NASDAQ:JANX). This move not only increased their total holdings to 10,742,993 shares but also amplified their influence within the company, marking a notable development in their investment strategy. Located at 200 Berkeley Street, Boston, RA Capital Management is a well-established firm with a strategic focus on the Healthcare and Financial Services sectors.

  • GuruFocus.com

    OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc

    On September 12, 2024, OrbiMed Advisors LLC, a prominent investment firm, executed a significant transaction by acquiring an additional 6,807,336 shares of Terns Pharmaceuticals Inc (NASDAQ:TERN). This purchase was made at a price of $9.51 per share, reflecting a strategic move by the firm to bolster its position in the biotechnology sector. Following this transaction, OrbiMed Advisors now holds a total of 7,562,971 shares in Terns Pharmaceuticals, marking a substantial increase in its investment portfolio.

  • GuruFocus.com

    RA Capital Management's Strategic Acquisition of Fulcrum Therapeutics Shares

    On September 12, 2024, RA Capital Management, L.P., a prominent investment firm, significantly increased its stake in Fulcrum Therapeutics Inc (NASDAQ:FULC) by acquiring an additional 4,684,883 shares. This move not only increased RA Capital's position in the company to 19.30% but also had a notable impact on its portfolio, representing a 0.46% position. Located at 200 Berkeley Street, Boston, RA Capital Management is a key player in the investment landscape, particularly focusing on the Healthcare and Financial Services sectors.